It's How Medicine Should Be®

Font Size:

-A +A

Translate

French German Italian Portuguese Russian

PARTNER II Trial

Clinical Trial Title: 
PARTNER II Trial: Placement of Aortic Transcatheter Valves Trial
Clinical Trial Protocol ID: 
11012002
Clinical Trial Investigator Name: 
Ziyad M. Hijazi, MD
Clinical Trial Protocol Description: 

The purpose of this trial is to determine the safety and effectiveness of an aortic valve device in patients with critical narrowing of the aortic valve that are deemed high risk and are not surgical candidates. The main goals are to successfully place the aortic valve device, relieving or possibly eliminating the narrowing in the valve, while avoiding complications.

Clinical Trial Eligibility Criteria: 

You may be eligible to participate in this study if you:

  • Have aortic valve stenosis
  • Are symptomatic from his/her aortic valve stenosis,
  • Have medical factors that may make them unable to have surgery to repair aortic valve
  • Agree to comply with all required post-procedure follow-up visits including annual visits through five years and analysis close date visits

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.

Clinical Trial Area: 
Heart and Vascular Conditions
Contact Phone: 
(312) 942-9565
Contact Name: 
Tiana Riley